{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:02:58Z","timestamp":1785294178757,"version":"3.55.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,19]],"date-time":"2010-11-19T00:00:00Z","timestamp":1290124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s11894-010-0157-5","type":"journal-article","created":{"date-parts":[[2010,11,18]],"date-time":"2010-11-18T03:13:37Z","timestamp":1290050017000},"page":"56-64","source":"Crossref","is-referenced-by-count":76,"title":["Advances in Alcoholic Liver Disease"],"prefix":"10.1007","volume":"13","author":[{"given":"Juliane I.","family":"Beier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin E.","family":"Arteel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"McClain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,19]]},"reference":[{"key":"157_CR1","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/S0021-9258(18)63504-5","volume":"244","author":"JM McCord","year":"1969","unstructured":"McCord JM, Fridovich I: Superoxide dismutase: an enzymatic function of erythrocuprein (hemocuprein). J Biol Chem 1969, 244:6049\u20136055.","journal-title":"J Biol Chem"},{"key":"157_CR2","doi-asserted-by":"crossref","unstructured":"Sies H: Oxidative stress: introductory remarks. In Oxidative Stress. Edited by Sies H. London:Academic Press; 1985:1\u20138.","DOI":"10.1016\/B978-0-12-642760-8.50005-3"},{"key":"157_CR3","first-page":"50","volume":"15","author":"NR Luzio Di","year":"1966","unstructured":"Di Luzio NR: A mechanism of the acute ethanol-induced fatty liver and the modification of liver injury by antioxidants. Lab Invest 1966; 15:50\u201363.","journal-title":"Lab Invest"},{"issue":"6","key":"157_CR4","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/ajcn\/32.6.1304","volume":"32","author":"AJ Patek Jr","year":"1979","unstructured":"Patek AJ Jr: Alcohol, malnutrition, and alcoholic cirrhosis. Am J Clin Nutr 1979; 32(6):1304\u20131312.","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"157_CR5","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1111\/j.1572-0241.2000.03347.x","volume":"95","author":"L Bujanda","year":"2000","unstructured":"Bujanda L: The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol 2000; 95(12):3374\u20133382.","journal-title":"Am J Gastroenterol"},{"key":"157_CR6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.nutr.20.1.395","volume":"20","author":"CS Lieber","year":"2000","unstructured":"Lieber CS: Alcohol: its metabolism and interaction with nutrients. Annu Rev Nutr 2000; 20:395\u2013430.","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"157_CR7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1053\/gast.2003.50087","volume":"124","author":"GE Arteel","year":"2003","unstructured":"Arteel GE: Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 2003; 124(3):778\u2013790.","journal-title":"Gastroenterology"},{"issue":"4","key":"157_CR8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0891-5849(00)00490-1","volume":"30","author":"H Kono","year":"2001","unstructured":"Kono H, Arteel GE, Rusyn I, et al.: Ebselen prevents early alcohol-induced liver injury in rats. Free Radic Biol Med 2001; 30(4):403\u2013411.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"157_CR9","doi-asserted-by":"crossref","first-page":"G1005","DOI":"10.1152\/ajpgi.2001.280.5.G1005","volume":"280","author":"H Kono","year":"2001","unstructured":"Kono H, Rusyn I, Uesugi T, et al.: Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat. Am J Physiol Gastrointest Liver Physiol 2001; 280(5):G1005\u2013G1012.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"157_CR10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0022-3565(24)39232-8","volume":"293","author":"H Kono","year":"2000","unstructured":"Kono H, Rusyn I, Connor H, et al.: Allopurinol prevents early alcohol-induced liver injury in rats. J Pharmacol Exp Therapeut 2000; 293(1):296\u2013303.","journal-title":"J Pharmacol Exp Therapeut"},{"key":"157_CR11","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/anie.198610581","volume":"25","author":"H Sies","year":"1986","unstructured":"Sies H.: Biochemistry of oxidative stress. Angew Chem Int Ed Engl 1986; 25: 1058\u20131071.","journal-title":"Angew Chem Int Ed Engl"},{"key":"157_CR12","doi-asserted-by":"crossref","unstructured":"Jones DP: The role of oxygen concentration in oxidative stress: hypoxic and hyperoxic models. In Oxidative Stress. Edited by Sies H. London:Academic Press; 1985:151\u2013195.","DOI":"10.1016\/B978-0-12-642760-8.50012-0"},{"issue":"4","key":"157_CR13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0006-2952(90)90152-B","volume":"39","author":"DL Tribble","year":"1990","unstructured":"Tribble DL, Jones DP: Oxygen dependence of oxidative stress: Rate of NADPH supply for maintaining the GSH pool during hypoxia. Biochem Pharmacol 1990; 39(4):729\u2013736.","journal-title":"Biochem Pharmacol"},{"key":"157_CR14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0741-8329(88)90010-9","volume":"5","author":"S Shaw","year":"1988","unstructured":"Shaw S, Jayatilleke E, Lieber CS: Lipid peroxidation as a mechanism of alcoholic liver injury: role of iron mobilization and microsomal induction. Alcohol 1988; 5:135\u2013140.","journal-title":"Alcohol"},{"issue":"1","key":"157_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/bbrc.2000.3889","volume":"279","author":"F Bardag-Gorce","year":"2000","unstructured":"Bardag-Gorce F, Yuan QX, Li J, et al.: The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol. Biochem Biophys Res Commun 2000; 279(1):23\u201329.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"157_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/135562101200100562","volume":"7","author":"TM Donohue Jr","year":"2002","unstructured":"Donohue TM Jr: The ubiquitin-proteasome system and its role in ethanol-induced disorders. Addict Biol 2002; 7(1):15\u201328.","journal-title":"Addict Biol"},{"issue":"1","key":"157_CR17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","volume":"82","author":"W Droge","year":"2002","unstructured":"Droge W: Free radicals in the physiological control of cell function. Physiol Rev 2002; 82(1):47\u201395.","journal-title":"Physiol Rev"},{"issue":"4\u20135","key":"157_CR18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0098-2997(01)00010-3","volume":"22","author":"HJ Forman","year":"2001","unstructured":"Forman HJ, Torres M: Redox signaling in macrophages. Mol Aspects Med 2001; 22(4\u20135):189\u2013216.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"157_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0898-6568(98)00037-0","volume":"11","author":"H Kamata","year":"1999","unstructured":"Kamata H, Hirata H: Redox regulation of cellular signalling. Cell Signal 1999; 11(1):1\u201314.","journal-title":"Cell Signal"},{"issue":"3","key":"157_CR20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0891-5849(99)00242-7","volume":"28","author":"RG Allen","year":"2000","unstructured":"Allen RG, Tresini M: Oxidative stress and gene regulation. Free Radic Biol Med 2000; 28(3):463\u2013499.","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"157_CR21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0161-5890(01)00108-0","volume":"38","author":"G Ermak","year":"2002","unstructured":"Ermak G, Davies KJ: Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 2002; 38(10):713\u2013721.","journal-title":"Mol Immunol"},{"issue":"1\u20132","key":"157_CR22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0891-5849(96)00275-4","volume":"22","author":"YJ Suzuki","year":"1997","unstructured":"Suzuki YJ, Forman HJ, Sevanian A: Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997; 22(1\u20132):269\u2013285.","journal-title":"Free Radic Biol Med"},{"issue":"1\u20132","key":"157_CR23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/mgme.2000.3074","volume":"71","author":"CT D\u2019Angio","year":"2000","unstructured":"D\u2019Angio CT, Finkelstein JN: Oxygen regulation of gene expression: a study in opposites. Mol Genet Metab 2000; 71(1\u20132):371\u2013380.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"157_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0741-8329(02)00215-X","volume":"27","author":"JB Hoek","year":"2002","unstructured":"Hoek JB, Pastorino JG: Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002; 27(1):63\u201368.","journal-title":"Alcohol"},{"issue":"11","key":"157_CR25","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3748\/wjg.v16.i11.1321","volume":"16","author":"G Szabo","year":"2010","unstructured":"Szabo G, Bala S: Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 2010; 16(11):1321\u20131329.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"157_CR26","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jhep.2009.03.007","volume":"50","author":"P Mandrekar","year":"2009","unstructured":"Mandrekar P, Szabo G: Signalling pathways in alcohol-induced liver inflammation. J Hepatol 2009; 50(6):1258\u20131266.","journal-title":"J Hepatol"},{"issue":"1","key":"157_CR27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","volume":"40","author":"E Mezey","year":"2004","unstructured":"\u2022 Mezey E, Potter JJ, Rennie-Tankersley L, et al.: A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol 2004; 40(1):40\u201346. In this study, the authors showed that a relatively high dose of vitamin E (1000 U) had no protective effect in patients with alcoholic hepatitis. The effectiveness of vitamin E alone was brought into question from the results of this study.","journal-title":"J Hepatol"},{"issue":"2","key":"157_CR28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","volume":"47","author":"S Stewart","year":"2007","unstructured":"\u2022\u2022 Stewart S, Prince M, Bassendine M, et al.: A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J Hepatol 2007; 47(2):277\u2013283. The authors of this study used a \u201ccocktail\u201d of antioxidants in patients with alcoholic hepatitis and did not observe any protective effect.","journal-title":"J Hepatol"},{"issue":"5","key":"157_CR29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.alcohol.2008.03.131","volume":"42","author":"V Purohit","year":"2008","unstructured":"Purohit V, Bode JC, Bode C, et al.: Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 2008; 42(5):349\u2013361.","journal-title":"Alcohol"},{"issue":"5","key":"157_CR30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/hep.21138","volume":"43","author":"T Gustot","year":"2006","unstructured":"Gustot T, Lemmers A, Moreno C, et al.: Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 2006; 43(5):989\u20131000.","journal-title":"Hepatology"},{"issue":"6","key":"157_CR31","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1749-6632.1954.tb36472.x","volume":"57","author":"TD Luckey","year":"1954","unstructured":"Luckey TD, Reyniers JA, Gyorgy P, et al.: Germfree animals and liver necrosis. Ann N Y Acad Sci 1954; 57(6):932\u2013935.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"157_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.106.1.1","volume":"106","author":"AM Rutenburg","year":"1957","unstructured":"Rutenburg AM, Sonnenblick E, Koven I, et al.: The role of intestinal bacteria in the development of dietary cirrhosis in rats. J Exp Med 1957; 106(1):1\u201314.","journal-title":"J Exp Med"},{"key":"157_CR33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.119.4.633","volume":"119","author":"SA Broitman","year":"1964","unstructured":"Broitman SA, Gottlieb LS, Zamcheck N: Influence of Neomycin and Ingested Endotoxin in the Pathogenesis of Choline Deficiency Cirrhosis in the Adult Rat. J Exp Med 1964; 119:633\u2013642.","journal-title":"J Exp Med"},{"issue":"1","key":"157_CR34","first-page":"127","volume":"52","author":"JP Nolan","year":"1979","unstructured":"Nolan JP: The contribution of gut-derived endotoxins to liver injury. Yale J Biol Med 1979; 52(1):127\u2013133.","journal-title":"Yale J Biol Med"},{"key":"157_CR35","first-page":"11","volume":"11","author":"GJ Gabuzda","year":"1962","unstructured":"Gabuzda GJ: Hepatic coma: clinical considerations, pathogenesis, and management. Adv Intern Med 1962; 11:11\u201373.","journal-title":"Adv Intern Med"},{"issue":"3","key":"157_CR36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archinte.118.3.211","volume":"118","author":"L Zieve","year":"1966","unstructured":"Zieve L: Pathogenesis of hepatic coma. Arch Intern Med 1966; 118(3):211\u2013223.","journal-title":"Arch Intern Med"},{"key":"157_CR37","unstructured":"McClain CJ, Zieve L: Portal Systemic Encephalopathy: Recognition and Variations. In Problems in Liver Diseases. Edited by Davidson CS. New York: Stratton Intercontinental Medical Book Corp.; 1979:162\u2013172."},{"issue":"1","key":"157_CR38","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0016-5085(95)90027-6","volume":"108","author":"Y Adachi","year":"1995","unstructured":"Adachi Y, Moore LE, Bradford BU, et al.: Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995; 108(1):218\u2013224.","journal-title":"Gastroenterology"},{"issue":"2","key":"157_CR39","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0022-3565(24)29249-1","volume":"299","author":"A Keshavarzian","year":"2001","unstructured":"Keshavarzian A, Choudhary S, Holmes EW, et al.: Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther 2001; 299(2):442\u2013448.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"157_CR40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3181\/00379727-205-43703","volume":"205","author":"AA Nanji","year":"1994","unstructured":"Nanji AA, Khettry U, Sadrzadeh SM: Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med 1994; 205(3):243\u2013247.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"3","key":"157_CR41","doi-asserted-by":"crossref","first-page":"G497","DOI":"10.1152\/ajpgi.00171.2004","volume":"287","author":"CJ McClain","year":"2004","unstructured":"McClain CJ, Song Z, Barve SS, et al.: Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004; 287(3):G497\u2013502.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"157_CR42","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/hep.510260621","volume":"26","author":"Y Iimuro","year":"1997","unstructured":"Iimuro Y, Gallucci RM, Luster MI, et al.: Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997; 26(6):1530\u20131537.","journal-title":"Hepatology"},{"issue":"4","key":"157_CR43","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0016-5085(99)70354-9","volume":"117","author":"M Yin","year":"1999","unstructured":"Yin M, Wheeler MD, Kono H, et al.: Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999; 117(4):942\u2013952.","journal-title":"Gastroenterology"},{"issue":"4","key":"157_CR44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1530-0277.1992.tb00656.x","volume":"16","author":"R Honchel","year":"1992","unstructured":"Honchel R, Ray MB, Marsano L, et al.: Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcohol Clin Exp Res 1992; 16(4):665\u2013669.","journal-title":"Alcohol Clin Exp Res"},{"issue":"11","key":"157_CR45","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3748\/wjg.v16.i11.1321","volume":"16","author":"G Szabo","year":"2010","unstructured":"\u2022 Szabo G, Bala S: Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 2010; 16(11):1321\u20131329. The authors review the interactions of gut flora, gut-derived toxins, and liver injury, including the role of tolls in liver injury.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"157_CR46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.1840090302","volume":"9","author":"CJ McClain","year":"1989","unstructured":"McClain CJ, Cohen DA: Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989; 9(3):349\u2013351.","journal-title":"Hepatology"},{"issue":"2","key":"157_CR47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.1840130211","volume":"13","author":"A Khoruts","year":"1991","unstructured":"Khoruts A, Stahnke L, McClain CJ, et al.: Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991; 13(2):267\u2013276.","journal-title":"Hepatology"},{"issue":"5","key":"157_CR48","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","volume":"39","author":"S Naveau","year":"2004","unstructured":"Naveau S, Chollet-Martin S, Dharancy S., et al.: A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004; 39(5):1390\u20131397.","journal-title":"Hepatology"},{"issue":"6","key":"157_CR49","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","volume":"135","author":"NC Boetticher","year":"2008","unstructured":"Boetticher NC, Peine CJ, Kwo P, et al.: A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology 2008; 135(6):1953\u20131960.","journal-title":"Gastroenterology"},{"key":"157_CR50","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","volume":"119","author":"E Akriviadis","year":"2000","unstructured":"Akriviadis E, Botla R, Briggs W, et al.: Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119:1637\u20131648.","journal-title":"Gastroenterology"},{"issue":"13","key":"157_CR51","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3748\/wjg.15.1613","volume":"15","author":"BK De","year":"2009","unstructured":"\u2022\u2022 De BK, Gangopadhyay S, Dutta D, Baksi SD, Pani A, Ghosh P. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial. World J Gastroenterol. 2009 Apr 7;15(13):1613\u20139. This article describes a randomized study that showed improved survival and renoprotection in alcoholic hepatitis with pentoxifylline compared to prednisolone.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"157_CR52","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1530-0277.1995.tb01560.x","volume":"19","author":"C Mendenhall","year":"1995","unstructured":"Mendenhall C, Roselle GA, Gartside P, et al.: Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. Alcohol Clin Exp Res 1995; 19(3):635\u2013641.","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"157_CR53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(84)90776-9","volume":"76","author":"CL Mendenhall","year":"1984","unstructured":"Mendenhall CL, Anderson S, Weesner RE, et al.: Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis. Am J Med 1984; 76(2):211\u2013222.","journal-title":"Am J Med"},{"issue":"4","key":"157_CR54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/0148607195019004258","volume":"19","author":"CL Mendenhall","year":"1995","unstructured":"Mendenhall CL, Moritz TE, Roselle GA, et al.: Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275. JPEN J Parenter Enteral Nutr 1995; 19(4):258\u2013265.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"2","key":"157_CR55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ajcn\/43.2.213","volume":"43","author":"CL Mendenhall","year":"1986","unstructured":"Mendenhall CL, Tosch T, Weesner RE, et al.: VA cooperative study on alcoholic hepatitis. II: Prognostic significance of protein-calorie malnutrition. Am J Clin Nutr 1986; 43(2):213\u2013218.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"157_CR56","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.1840170407","volume":"17","author":"CL Mendenhall","year":"1993","unstructured":"Mendenhall CL, Moritz TE, Roselle GA, et al.: A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 1993; 17(4):564\u2013576.","journal-title":"Hepatology"},{"issue":"1","key":"157_CR57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","volume":"32","author":"E Cabre","year":"2000","unstructured":"Cabre E, Rodriguez-Iglesias P, Caballeria J, et al.: Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 2000; 32(1):36\u201342.","journal-title":"Hepatology"},{"issue":"2","key":"157_CR58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hep.22367","volume":"48","author":"LD Plank","year":"2008","unstructured":"\u2022\u2022 Plank LD, Gane EJ, Peng S, et al.: Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. Hepatology 2008; 48(2):557\u2013566. This article documents the importance of nighttime snacks in maintaining muscle mass in cirrhotics. Patients with cirrhosis can transition to a \u201cstarvation\u201d state overnight.","journal-title":"Hepatology"},{"issue":"4\u20135","key":"157_CR59","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.mam.2005.07.002","volume":"26","author":"YJ Kang","year":"2005","unstructured":"Kang YJ, Zhou Z.: Zinc prevention and treatment of alcoholic liver disease. Mol Aspects Med 2005; 26(4\u20135):391\u2013404.","journal-title":"Mol Aspects Med"},{"issue":"6","key":"157_CR60","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1530-0277.1986.tb05149.x","volume":"10","author":"CJ McClain","year":"1986","unstructured":"McClain CJ, Antonow DR, Cohen DA, et al.: Zinc metabolism in alcoholic liver disease. Alcohol Clin Exp Res 1986; 10(6):582\u2013589.","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"157_CR61","first-page":"622","volume":"232","author":"Z Zhou","year":"2007","unstructured":"Zhou Z, Kang X, Jiang Y, et al.: Preservation of hepatocyte nuclear factor-4alpha is associated with zinc protection against TNF-alpha hepatotoxicity in mice. Exp Biol Med (Maywood) 2007; 232(5):622\u2013628.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"5","key":"157_CR62","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/153537020623100509","volume":"231","author":"M Shea-Budgell","year":"2006","unstructured":"Shea-Budgell M, Dojka M, Nimmo M, et al.: Marginal zinc deficiency increased the susceptibility to acute lipopolysaccharide-induced liver injury in rats. Exp Biol Med (Maywood) 2006; 231(5):553\u2013558.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"157_CR63","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/153537020322800411","volume":"228","author":"JC Lambert","year":"2003","unstructured":"Lambert JC, Zhou Z, Kang YJ: Suppression of Fas-mediated signaling pathway is involved in zinc inhibition of ethanol-induced liver apoptosis. Exp Biol Med (Maywood) 2003; 228(4):406\u2013412.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"5","key":"157_CR64","doi-asserted-by":"crossref","first-page":"G625","DOI":"10.1152\/ajpgi.00350.2009","volume":"298","author":"W Zhong","year":"2010","unstructured":"Zhong W, McClain CJ, Cave M, et al.: The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction. Am J Physiol Gastrointest Liver Physiol 2010; 298(5):G625\u2013633.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"157_CR65","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1165\/rcmb.2008-0209OC","volume":"41","author":"PC Joshi","year":"2009","unstructured":"Joshi PC, Mehta A, Jabber WS, et al.: Zinc deficiency mediates alcohol-induced alveolar epithelial and macrophage dysfunction in rats. Am J Respir Cell Mol Biol 2009; 41(2):207\u2013216.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"157_CR66","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1872-034X.2007.00065.x","volume":"37","author":"M Takahashi","year":"2007","unstructured":"Takahashi M, Saito H, Higashimoto M, et al.: Possible inhibitory effect of oral zinc supplementation on hepatic fibrosis through downregulation of TIMP-1: A pilot study. Hepatol Res 2007; 37(6):405\u2013409.","journal-title":"Hepatol Res"},{"issue":"1","key":"157_CR67","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1538-7836.2007.02772.x","volume":"6","author":"PG Northup","year":"2008","unstructured":"\u2022 Northup PG, Sundaram V, Fallon MB, et al.: Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost 2008; 6(1):2\u20139. This review is a state-of-the-art proceeding from the first Coagulopathy in Liver Disease conference held in Charlottesville, VA, USA. All authors presented at the conference on a separate topic concerning hypercoagulation in liver disease.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"157_CR68","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1055\/s-0037-1613567","volume":"89","author":"K Kolev","year":"2003","unstructured":"Kolev K, Machovich R: Molecular and cellular modulation of fibrinolysis. Thromb Haemost 2003; 89(4):610\u2013621.","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"157_CR69","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1111\/j.1440-1746.2007.05285.x","volume":"23","author":"GE Arteel","year":"2008","unstructured":"Arteel GE: New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury. J Gastroenterol Hepatol 2008; 23 Suppl 1:S54\u201359.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"157_CR70","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.108.136721","volume":"325","author":"JI Beier","year":"2008","unstructured":"Beier JI, Guo L, von Montfort C, et al.: New role of resistin in lipopolysaccharide-induced liver damage in mice. J Pharmacol Exp Ther 2008; 325(3):801\u2013808.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"157_CR71","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/hep.22847","volume":"49","author":"JI Beier","year":"2009","unstructured":"Beier JI, Luyendyk JP, Guo L, et al.: Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice. Hepatology 2009; 49(5):1545\u20131553.","journal-title":"Hepatology"},{"issue":"7","key":"157_CR72","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1053\/j.gastro.2006.03.020","volume":"130","author":"I Bergheim","year":"2006","unstructured":"\u2022 Bergheim I, Guo L, Davis MA, et al.: Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1. Gastroenterology 2006; 130(7):2099\u20132112. This article is the first to show that steatosis due to acute or chronic enteral alcohol exposure was blunted by blocking PAI-1 induction, independent of AMPK activation.","journal-title":"Gastroenterology"},{"issue":"2","key":"157_CR73","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1124\/jpet.105.095042","volume":"316","author":"I Bergheim","year":"2006","unstructured":"Bergheim I, Guo L, Davis MA, et al.: Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis. J Pharmacol Exp Ther 2006; 316(2):592\u2013600.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"157_CR74","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cbi.2004.09.002","volume":"150","author":"PE Ganey","year":"2004","unstructured":"Ganey PE, Luyendyk JP, Maddox JF, et al.: Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor. Chem Biol Interact 2004; 150(1):35\u201351.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"157_CR75","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0022-3565(25)20145-8","volume":"278","author":"JM Pearson","year":"1996","unstructured":"Pearson JM, Schultze AE, Schwartz KA, et al.: The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat. J Pharmacol Exp Ther 1996; 278(1):378\u2013383.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"157_CR76","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00441-003-0774-5","volume":"314","author":"KM Hodivala-Dilke","year":"2003","unstructured":"Hodivala-Dilke KM, Reynolds AR, Reynolds LE: Integrins in angiogenesis: multitalented molecules in a balancing act. Cell Tissue Res 2003; 314(1):131\u2013144.","journal-title":"Cell Tissue Res"},{"issue":"9","key":"157_CR77","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1096\/fj.09-129874","volume":"23","author":"HF Zhou","year":"2009","unstructured":"Zhou HF, Chan HW, Wickline SA, et al.: Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice. FASEB J 2009; 23(9):2978\u20132985.","journal-title":"FASEB J"},{"issue":"6","key":"157_CR78","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1160\/TH08-07-0490","volume":"100","author":"EY Dimova","year":"2008","unstructured":"Dimova EY, Kietzmann T: Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver. Thromb Haemost 2008; 100(6):992\u20131006.","journal-title":"Thromb Haemost"},{"issue":"2","key":"157_CR79","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0038-1646877","volume":"62","author":"C Tran-Thang","year":"1989","unstructured":"Tran-Thang C, Fasel-Felley J, Pralong G, et al.: Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis. Thromb Haemost 1989; 62(2):651\u2013653.","journal-title":"Thromb Haemost"},{"issue":"4","key":"157_CR80","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jhep.2007.12.015","volume":"48","author":"D Seth","year":"2008","unstructured":"Seth D, Hogg PJ, Gorrell MD, et al.: Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. J Hepatol 2008; 48(4):614\u2013627.","journal-title":"J Hepatol"},{"issue":"2","key":"157_CR81","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2010.01.042","volume":"53","author":"T Lisman","year":"2010","unstructured":"Lisman T, Caldwell SH, Burroughs AK, et al.: Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol 2010; 53(2):362\u2013371.","journal-title":"J Hepatol"},{"issue":"3","key":"157_CR82","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2001-17556","volume":"21","author":"D Schuppan","year":"2001","unstructured":"Schuppan D, Ruehl M, Somasundaram R, et al.: Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 2001; 21(3):351\u2013372.","journal-title":"Semin Liver Dis"},{"issue":"2","key":"157_CR83","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(01)00260-4","volume":"36","author":"D Cassiman","year":"2002","unstructured":"Cassiman D, Libbrecht L, Desmet V, et al.: Hepatic stellate cell\/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002; 36(2):200\u2013209.","journal-title":"J Hepatol"},{"issue":"32","key":"157_CR84","doi-asserted-by":"crossref","first-page":"23337","DOI":"10.1074\/jbc.M700194200","volume":"282","author":"M Zeisberg","year":"2007","unstructured":"Zeisberg M, Yang C, Martino M, et al.: Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007; 282(32):23337\u201323347.","journal-title":"J Biol Chem"},{"issue":"4","key":"157_CR85","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.21624","volume":"45","author":"H Robertson","year":"2007","unstructured":"Robertson H, Kirby JA, Yip WW, et al.: Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology 2007; 45(4):977\u2013981.","journal-title":"Hepatology"},{"issue":"10","key":"157_CR86","first-page":"3331","volume":"118","author":"A Omenetti","year":"2008","unstructured":"Omenetti A, Porrello A, Jung Y, et al.: Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 2008; 118(10):3331\u20133342.","journal-title":"J Clin Invest"},{"issue":"4","key":"157_CR87","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cld.2008.07.001","volume":"12","author":"RG Gieling","year":"2008","unstructured":"Gieling RG, Burt AD, Mann DA: Fibrosis and cirrhosis reversibility - molecular mechanisms. Clin Liver Dis 2008; 12(4):915\u2013937, xi.","journal-title":"Clin Liver Dis"},{"issue":"5","key":"157_CR88","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","volume":"122","author":"T Poynard","year":"2002","unstructured":"\u2022\u2022 Poynard T, McHutchison J, Manns M, et al.: Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002; 122(5):1303\u20131313. In this seminal work, the authors showed that \u201cend-stage\u201d liver disease may revert in some patients, if the underlying cause is effectively treated. This work sparked great interest in identifying new therapies to accelerate reversion of fibrosis\/cirrhosis in experimental models and in patients.","journal-title":"Gastroenterology"},{"issue":"3","key":"157_CR89","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","volume":"102","author":"JP Iredale","year":"1998","unstructured":"Iredale JP, Benyon RC, Pickering J, et al.: Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102(3):538\u2013549.","journal-title":"J Clin Invest"},{"issue":"1","key":"157_CR90","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2005.01192.x","volume":"26","author":"X Liu","year":"2006","unstructured":"Liu X, Hu H, Yin JQ: Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int 2006; 26(1):8\u201322.","journal-title":"Liver Int"},{"issue":"2","key":"157_CR91","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11095-007-9311-7","volume":"25","author":"Y Iimuro","year":"2008","unstructured":"Iimuro Y, Brenner DA: Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res 2008; 25(2):249\u2013258.","journal-title":"Pharm Res"},{"issue":"3","key":"157_CR92","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2001-17552","volume":"21","author":"RC Benyon","year":"2001","unstructured":"Benyon RC, Arthur MJ: Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001; 21(3):373\u2013384.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"157_CR93","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1172\/JCI118077","volume":"96","author":"H Tsukamoto","year":"1995","unstructured":"Tsukamoto H, Horne W, Kamimura S, et al.: Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 1995; 96(1):620\u2013630.","journal-title":"J Clin Invest"},{"issue":"3","key":"157_CR94","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","volume":"117","author":"JP Iredale","year":"2007","unstructured":"Iredale JP: Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007; 117(3):539\u2013548.","journal-title":"J Clin Invest"},{"key":"157_CR95","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev.pharmtox.45.120403.095906","volume":"45","author":"S Lotersztajn","year":"2005","unstructured":"Lotersztajn S, Julien B, Teixeira-Clerc F, et al.: Hepatic fibrosis: molecular mechanisms and drug targets. Annu Rev Pharmacol Toxicol 2005; 45:605\u2013628.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"157_CR96","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1053\/j.gastro.2010.01.040","volume":"138","author":"D Lebrec","year":"2010","unstructured":"Lebrec D, Thabut D, Oberti F, et al.: Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology 2010; 138(5):1755\u20131762.","journal-title":"Gastroenterology"},{"issue":"3","key":"157_CR97","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","volume":"48","author":"A Louvet","year":"2008","unstructured":"Louvet A, Diaz E, Dharancy S, et al.: Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. J Hepatol 2008; 48(3):465\u2013470.","journal-title":"J Hepatol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-010-0157-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-010-0157-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-010-0157-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T01:39:42Z","timestamp":1740706782000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-010-0157-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,19]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["157"],"URL":"https:\/\/doi.org\/10.1007\/s11894-010-0157-5","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,19]]}}}